Journey Medical Corporation (DERM)

Journey Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Quarter	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
Cash & Equivalents	27.22	24.09	24.95	20.29	21.07	20.31	22.46	23.91	24.06	27.44	24.75	16.98	26.1	32	34.89	38.14	41.33	49.08	21.69	12.18
Cash & Short-Term Investments	27.22	24.09	24.95	20.29	21.07	20.31	22.46	23.91	24.06	27.44	24.75	16.98	26.1	32	34.89	38.14	41.33	49.08	21.69	12.18
Cash Growth	29.18%	18.64%	11.07%	-15.14%	-12.42%	-26.00%	-9.25%	40.82%	-7.82%	-14.26%	-29.07%	-55.48%	-36.85%	-34.80%	60.87%	213.26%	239.45%	495.21%	163.02%	153.61%
Accounts Receivable	24.99	29.78	17.98	15.64	18.03	10.23	10.67	10.47	9.8	15.22	7.99	16.74	27.62	28.21	28.53	28.67	31.18	23.11	31.74	26.19
Inventory	9.29	9.62	11.82	12.85	12.5	14.43	11.79	9.69	10.58	10.21	11.02	12.17	13.28	14.16	15.23	16.05	16.14	9.86	11.61	14.32
Other Current Assets	3.46	3.38	1.64	2.48	2.4	3.21	1.24	2.41	2.58	3.59	0.92	1.8	2.48	3.31	0.94	1.04	1.61	2.44	1.75	0.79
Total Current Assets	64.97	66.87	56.39	51.27	53.99	48.18	46.16	46.47	47.01	56.46	44.69	47.68	60.72	77.68	79.6	83.9	90.26	84.49	66.8	53.47
Net Property, Plant & Equipment	0.09	0.11	0.13	0.16	0.18	0.2	0.03	0.06	0.08	0.1	0.12	0.15	0.17	0.19	0.02	0.05	0.07	0.09	0.11	0.13
Other Intangible Assets	26.48	27.61	28.67	29.73	30.8	31.86	17.84	18.66	19.47	20.29	21.1	21.92	26.13	27.2	28.42	29.44	30.46	12.55	13.04	13.7
Other Long-Term Assets	-	-	-	-	-	-	0.01	0.01	0.01	0.01	0.01	0.01	0.09	0.1	0.1	0.11	0.12	0.15	9.11	5.42
Total Assets	91.53	94.59	85.19	81.16	84.96	80.24	64.04	65.19	66.57	76.85	65.92	69.75	95.85	105.16	108.15	113.5	120.9	97.28	89.06	72.73
Accounts Payable	8.67	9.31	12.31	13.59	14.8	16.58	15.71	14.86	15.54	18.34	29.26	32.38	44.03	36.98	33.7	33.11	27.47	23.45	28.78	4.59
Accrued Expenses	26.49	27.97	21.61	22.97	23.39	17.83	16.34	16.22	20.27	20.37	16.03	23.41	17.54	19.55	17.91	19.45	25.95	22.73	26.48	35.86
Short-Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	3	2.95	-	-	-	0.81	-	-
Current Portion of Long-Term Debt	2.5	-	5.63	3.75	1.88	-	-	-	-	-	-	9.94	9.91	-	-	-	-	-	-	-
Current Portion of Leases	0.09	0.1	0.1	0.1	0.09	0.08	0.03	0.06	0.08	0.1	0.1	0.1	0.09	0.08	0.03	0.05	0.07	0.1	0.1	0.09
Other Current Liabilities	0.07	0.07	0.07	0.07	0.06	0.69	1.25	3	3.04	3.05	3.13	2.37	2.32	7.27	9.14	7.5	7.48	4.52	4.43	3.86
Total Current Liabilities	37.83	37.44	39.72	40.48	40.22	35.18	33.33	34.15	38.94	41.87	48.51	68.19	76.9	66.83	60.78	60.1	60.97	51.61	59.79	44.41
Long-Term Debt	22.87	25.28	19.53	21.36	23.11	24.88	19.79	19.75	14.68	14.62	-	-	9.93	19.83	19.81	14.79	14.78	-	33.05	18.34
Long-Term Leases	-	0.02	0.04	0.07	0.09	0.12	-	-	-	0.01	0.03	0.06	0.08	0.11	-	-	-	-	0.02	0.05
Other Long-Term Liabilities	-	-	-	-	-	-	-	-	-	-	-	1.49	1.45	1.41	1.37	3.81	3.72	3.63	7.9	10.72
Total Long-Term Liabilities	22.87	25.3	19.58	21.43	23.2	25	19.79	19.75	14.68	14.63	0.03	1.55	11.46	21.35	21.18	18.6	18.49	3.63	40.98	29.11
Total Liabilities	60.7	62.74	59.29	61.91	63.42	60.17	53.12	53.89	53.62	56.5	48.54	69.74	88.36	88.18	81.96	78.7	79.46	55.24	100.77	73.52
Common Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid-in Capital	131.52	130.31	123.11	114.14	112.64	107.09	99.47	97.45	95.75	92.7	87.58	87	86.13	85.48	84.04	82.57	81.69	80.92	5.41	5.68
Retained Earnings	-100.69	-98.46	-97.21	-94.9	-91.1	-87.03	-88.55	-86.16	-82.8	-72.36	-70.21	-87	-78.64	-68.5	-57.86	-47.78	-40.25	-38.87	-17.12	-6.48
Shareholders' Equity	30.83	31.85	25.9	19.25	21.54	20.07	10.93	11.3	12.95	20.35	17.37	0.01	7.49	16.98	26.18	34.8	41.44	42.04	-11.71	-0.79
Total Liabilities & Equity	91.53	94.59	85.19	81.16	84.96	80.24	64.04	65.19	66.57	76.85	65.92	69.75	95.85	105.16	108.15	113.5	120.9	97.28	89.06	72.73
Total Debt	25.47	25.4	25.3	25.28	25.17	25.08	19.82	19.81	14.77	14.73	0.13	10.1	23.02	22.97	19.84	14.84	14.85	0.91	33.17	18.48
Net Cash (Debt)	1.75	-1.31	-0.35	-4.98	-4.1	-4.78	2.64	4.11	9.29	12.71	24.62	6.88	3.08	9.04	15.06	23.3	26.48	48.17	-11.48	-6.3
Net Cash Growth	-	-	-	-	-	-	-89.27%	-40.37%	201.69%	40.62%	63.51%	-70.45%	-88.37%	-81.24%	-	-	-	1593.78%	-	-
Net Cash Per Share	0.06	-0.05	-0.01	-0.21	-0.18	-0.22	0.13	0.20	0.47	0.68	1.17	0.38	0.17	0.51	0.85	1.33	1.53	3.64	-1.25	-0.69
Book Value	30.83	31.85	25.9	19.25	21.54	20.07	10.93	11.3	12.95	20.35	17.37	0.01	7.49	16.98	26.18	34.8	41.44	42.04	-11.71	-0.79
Book Value Per Share	1.13	1.18	1.04	0.83	0.95	0.94	0.53	0.56	0.66	1.09	0.83	0.00	0.42	0.96	1.49	1.99	2.39	3.17	-1.28	-0.09
Tangible Book Value	4.35	4.25	-2.77	-10.49	-9.26	-11.79	-6.92	-7.36	-6.52	0.06	-3.73	-21.91	-18.64	-10.22	-2.24	5.36	10.98	29.49	-24.75	-14.49
Tangible Book Value Per Share	0.16	0.16	-0.11	-0.45	-0.41	-0.55	-0.34	-0.37	-0.33	0.00	-0.18	-1.22	-1.05	-0.58	-0.13	0.31	0.63	2.23	-2.70	-1.58

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: May 13, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 15, 2026

Data Sources Report a data error